Global NSCLC Drugs Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the NSCLC Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in NSCLC Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of NSCLC Drugs market by type, application, key companies and key regions.
This study considers the NSCLC Drugs value generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Oral Type
Injection Type
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Squamous Cell Lung Carcinoma
Large-cell Lung Carcinoma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
AstraZeneca
Bristol-Myers Squibb
Novartis
Jiangsu Hengrui Medicine
Regeneron Pharmaceuticals
BeiGene
Innovent Biologics
Roche
Shanghai Junshi Biosciences
Pfizer
Teva
Boehringer-Ingelheim
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global NSCLC Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of NSCLC Drugs market by identifying its various subsegments.
Focuses on the key global NSCLC Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the NSCLC Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of NSCLC Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global NSCLC Drugs Market Size 2015-2025
2.1.2 NSCLC Drugs Market Size CAGR by Region
2.2 NSCLC Drugs Segment by Type
2.2.1 Oral Type
2.2.2 Oral Type
2.3 NSCLC Drugs Market Size by Type
2.3.1 Global NSCLC Drugs Market Size Market Share by Type (2015-2020)
2.3.2 Global NSCLC Drugs Market Size Growth Rate by Type (2015-2020)
2.4 NSCLC Drugs Segment by Application
2.4.1 Squamous Cell Lung Carcinoma
2.4.2 Large-cell Lung Carcinoma
2.5 NSCLC Drugs Market Size by Application
2.5.1 Global NSCLC Drugs Market Size Market Share by Application (2015-2020)
2.5.2 Global NSCLC Drugs Market Size Growth Rate by Application (2015-2020)
3 Global NSCLC Drugs by Players
3.1 Global NSCLC Drugs Market Size Market Share by Players
3.1.1 Global NSCLC Drugs Market Size by Players (2018-2020)
3.1.2 Global NSCLC Drugs Market Size Market Share by Players (2018-2020)
3.2 Global NSCLC Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NSCLC Drugs by Regions
4.1 NSCLC Drugs Market Size by Regions
4.2 Americas NSCLC Drugs Market Size Growth
4.3 APAC NSCLC Drugs Market Size Growth
4.4 Europe NSCLC Drugs Market Size Growth
4.5 Middle East & Africa NSCLC Drugs Market Size Growth
5 Americas
5.1 Americas NSCLC Drugs Market Size by Countries
5.2 Americas NSCLC Drugs Market Size by Type
5.3 Americas NSCLC Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC NSCLC Drugs Market Size by Regions
6.2 APAC NSCLC Drugs Market Size by Type
6.3 APAC NSCLC Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe NSCLC Drugs by Countries
7.2 Europe NSCLC Drugs Market Size by Type
7.3 Europe NSCLC Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa NSCLC Drugs by Countries
8.2 Middle East & Africa NSCLC Drugs Market Size by Type
8.3 Middle East & Africa NSCLC Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global NSCLC Drugs Market Forecast
10.1 Global NSCLC Drugs Market Size Forecast (2021-2025)
10.2 Global NSCLC Drugs Forecast by Regions
10.2.1 Global NSCLC Drugs Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global NSCLC Drugs Forecast by Type
10.8 Global NSCLC Drugs Forecast by Application
11 Key Players Analysis
11.1 Merck
11.1.1 Company Details
11.1.2 NSCLC Drugs Product Offered
11.1.3 Merck NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Merck News
11.2 AstraZeneca
11.2.1 Company Details
11.2.2 NSCLC Drugs Product Offered
11.2.3 AstraZeneca NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 AstraZeneca News
11.3 Bristol-Myers Squibb
11.3.1 Company Details
11.3.2 NSCLC Drugs Product Offered
11.3.3 Bristol-Myers Squibb NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Bristol-Myers Squibb News
11.4 Novartis
11.4.1 Company Details
11.4.2 NSCLC Drugs Product Offered
11.4.3 Novartis NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Novartis News
11.5 Jiangsu Hengrui Medicine
11.5.1 Company Details
11.5.2 NSCLC Drugs Product Offered
11.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Jiangsu Hengrui Medicine News
11.6 Regeneron Pharmaceuticals
11.6.1 Company Details
11.6.2 NSCLC Drugs Product Offered
11.6.3 Regeneron Pharmaceuticals NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Regeneron Pharmaceuticals News
11.7 BeiGene
11.7.1 Company Details
11.7.2 NSCLC Drugs Product Offered
11.7.3 BeiGene NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 BeiGene News
11.8 Innovent Biologics
11.8.1 Company Details
11.8.2 NSCLC Drugs Product Offered
11.8.3 Innovent Biologics NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Innovent Biologics News
11.9 Roche
11.9.1 Company Details
11.9.2 NSCLC Drugs Product Offered
11.9.3 Roche NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 Roche News
11.10 Shanghai Junshi Biosciences
11.10.1 Company Details
11.10.2 NSCLC Drugs Product Offered
11.10.3 Shanghai Junshi Biosciences NSCLC Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Shanghai Junshi Biosciences News
11.11 Pfizer
11.12 Teva
11.13 Boehringer-Ingelheim
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. NSCLC Drugs Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral Type
Table 5. Major Players of Injection Type
Table 6. NSCLC Drugs Market Size by Type (2014-2019) ($ Millions)
Table 7. Global NSCLC Drugs Market Size Market Share by Type (2015-2020)
Table 8. Global NSCLC Drugs Market Size by Application (2015-2020) ($ Millions)
Table 9. Global NSCLC Drugs Market Size Market Share by Application (2015-2020)
Table 10. Global NSCLC Drugs Revenue by Players (2018-2020) ($ Millions)
Table 11. Global NSCLC Drugs Revenue Market Share by Players (2018-2020)
Table 12. Global NSCLC Drugs Key Players Head office and Products Offered
Table 13. NSCLC Drugs Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global NSCLC Drugs Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global NSCLC Drugs Market Size Market Share by Regions 2015-2020
Table 18. Americas NSCLC Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas NSCLC Drugs Market Size Market Share by Countries (2015-2020)
Table 20. Americas NSCLC Drugs Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas NSCLC Drugs Market Size Market Share by Type (2015-2020)
Table 22. Americas NSCLC Drugs Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas NSCLC Drugs Market Size Market Share by Application (2015-2020)
Table 24. APAC NSCLC Drugs Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC NSCLC Drugs Market Size Market Share by Regions (2015-2020)
Table 26. APAC NSCLC Drugs Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC NSCLC Drugs Market Size Market Share by Type (2015-2020)
Table 28. APAC NSCLC Drugs Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC NSCLC Drugs Market Size Market Share by Application (2015-2020)
Table 30. Europe NSCLC Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe NSCLC Drugs Market Size Market Share by Countries (2015-2020)
Table 32. Europe NSCLC Drugs Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe NSCLC Drugs Market Size Market Share by Type (2015-2020)
Table 34. Europe NSCLC Drugs Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe NSCLC Drugs Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa NSCLC Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa NSCLC Drugs Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa NSCLC Drugs Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa NSCLC Drugs Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa NSCLC Drugs Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa NSCLC Drugs Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of NSCLC Drugs
Table 43. Key Application and Potential Industries of NSCLC Drugs
Table 44. Key Challenges of NSCLC Drugs
Table 45. Key Trends of NSCLC Drugs
Table 46. Global NSCLC Drugs Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global NSCLC Drugs Market Size Market Share Forecast by Regions
Table 48. Global NSCLC Drugs Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global NSCLC Drugs Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global NSCLC Drugs Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global NSCLC Drugs Market Size Market Share Forecast by Application (2021-2025)
Table 52. Merck Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 53. Merck NSCLC Drugs Product Offered
Table 54. Merck NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 55. Merck Main Business
Table 56. Merck Latest Developments
Table 57. AstraZeneca Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 58. AstraZeneca NSCLC Drugs Product Offered
Table 59. AstraZeneca Main Business
Table 60. AstraZeneca NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 61. AstraZeneca Latest Developments
Table 62. Bristol-Myers Squibb Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 63. Bristol-Myers Squibb NSCLC Drugs Product Offered
Table 64. Bristol-Myers Squibb Main Business
Table 65. Bristol-Myers Squibb NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 66. Bristol-Myers Squibb Latest Developments
Table 67. Novartis Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 68. Novartis NSCLC Drugs Product Offered
Table 69. Novartis Main Business
Table 70. Novartis NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 71. Novartis Latest Developments
Table 72. Jiangsu Hengrui Medicine Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 73. Jiangsu Hengrui Medicine NSCLC Drugs Product Offered
Table 74. Jiangsu Hengrui Medicine Main Business
Table 75. Jiangsu Hengrui Medicine NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 76. Jiangsu Hengrui Medicine Latest Developments
Table 77. Regeneron Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 78. Regeneron Pharmaceuticals NSCLC Drugs Product Offered
Table 79. Regeneron Pharmaceuticals Main Business
Table 80. Regeneron Pharmaceuticals NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 81. Regeneron Pharmaceuticals Latest Developments
Table 82. BeiGene Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 83. BeiGene NSCLC Drugs Product Offered
Table 84. BeiGene Main Business
Table 85. BeiGene NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 86. BeiGene Latest Developments
Table 87. Innovent Biologics Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 88. Innovent Biologics NSCLC Drugs Product Offered
Table 89. Innovent Biologics Main Business
Table 90. Innovent Biologics NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 91. Innovent Biologics Latest Developments
Table 92. Roche Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 93. Roche NSCLC Drugs Product Offered
Table 94. Roche Main Business
Table 95. Roche NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 96. Roche Latest Developments
Table 97. Shanghai Junshi Biosciences Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 98. Shanghai Junshi Biosciences NSCLC Drugs Product Offered
Table 99. Shanghai Junshi Biosciences Main Business
Table 100. Shanghai Junshi Biosciences NSCLC Drugs Revenue and Gross Margin (2018-2020E)
Table 101. Shanghai Junshi Biosciences Latest Developments
Table 102. Pfizer Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 103. Teva Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
Table 104. Boehringer-Ingelheim Details, Company Total Revenue (in $ million), Head Office, NSCLC Drugs Major Market Areas and Its Competitors
List of Figures
Figure 1. NSCLC Drugs Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global NSCLC Drugs Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global NSCLC Drugs Market Size Market Share by Type (2015-2020)
Figure 5. Global Oral Type Market Size Growth Rate
Figure 6. Global Injection Type Market Size Growth Rate
Figure 7. NSCLC Drugs in Squamous Cell Lung Carcinoma
Figure 8. Global NSCLC Drugs Market: Squamous Cell Lung Carcinoma (2015-2020) ($ Millions)
Figure 9. NSCLC Drugs in Large-cell Lung Carcinoma
Figure 10. Global NSCLC Drugs Market: Large-cell Lung Carcinoma (2015-2020) ($ Millions)
Figure 11. Global NSCLC Drugs Market Size Market Share by Application in 2019
Figure 12. Global NSCLC Drugs Market Size Market Share by Regions 2015-2020
Figure 13. Americas NSCLC Drugs Market Size 2015-2020 ($ Millions)
Figure 14. APAC NSCLC Drugs Market Size 2015-2020 ($ Millions)
Figure 15. Europe NSCLC Drugs Market Size 2015-2020 ($ Millions)
Figure 16. Middle East & Africa NSCLC Drugs Market Size 2015-2020 ($ Millions)
Figure 17. Americas NSCLC Drugs Market Size Market Share by Countries in 2019
Figure 18. Americas NSCLC Drugs Market Size Market Share by Type in 2019
Figure 19. Americas NSCLC Drugs Market Size Market Share by Application in 2019
Figure 20. United States NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 21. Canada NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 22. Mexico NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 23. APAC NSCLC Drugs Market Size Market Share by Regions in 2019
Figure 24. APAC NSCLC Drugs Market Size Market Share by Type in 2019
Figure 25. APAC NSCLC Drugs Market Size Market Share by Application in 2019
Figure 26. China NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 27. Japan NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 28. Korea NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 29. Southeast Asia NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 30. India NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 31. Australia NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 32. Europe NSCLC Drugs Market Size Market Share by Countries in 2019
Figure 33. Europe NSCLC Drugs Market Size Market Share by Type in 2019
Figure 34. Europe NSCLC Drugs Market Size Market Share by Application in 2019
Figure 35. Germany NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 36. France NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 37. UK NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 38. Italy NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 39. Russia NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 40. Spain NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 41. Middle East & Africa NSCLC Drugs Market Size Market Share by Countries in 2019
Figure 42. Middle East & Africa NSCLC Drugs Market Size Market Share by Type in 2019
Figure 43. Middle East & Africa NSCLC Drugs Market Size Market Share by Application in 2019
Figure 44. Egypt NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 45. South Africa NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 46. Israel NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 47. Turkey NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 48. GCC Countries NSCLC Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 49. Global NSCLC Drugs arket Size Forecast (2021-2025) ($ Millions)
Figure 50. Americas NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 51. APAC NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 52. Europe NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 53. Middle East & Africa NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 54. United States NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 55. Canada NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 56. Mexico NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 57. Brazil NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 58. China NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 59. Japan NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 60. Korea NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 61. Southeast Asia NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 62. India NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 63. Australia NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 64. Germany NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 65. France NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 66. UK NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 67. Italy NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 68. Russia NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 69. Spain NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 70. Egypt NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 71. South Africa NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 72. Israel NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 73. Turkey NSCLC Drugs Market Size 2021-2025 ($ Millions)
Figure 74. GCC Countries NSCLC Drugs Market Size 2021-2025 ($ Millions)
